BioCentury
ARTICLE | Clinical News

ThPTH: Phase I data

May 10, 2004 7:00 AM UTC

In a cross-over Phase I trial in 20 female subjects, ThPTH delivered PTH at blood levels similar to subcutaneous Forteo. Urinary cyclic AMP (cAMP) levels increased within 2 hours of administration fo...